|

Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia

RECRUITINGSponsored by Centre Hospitalier Universitaire, Amiens
Actively Recruiting
SponsorCentre Hospitalier Universitaire, Amiens
Started2010-09-16
Est. completion2035-04
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The aortic valve bicuspidia (BVA) is a congenital condition corresponding to the presence of 2 sigmoids instead of 3. This is the most common cardiac congenital anomaly affecting 0.5 to 2% of the population The general rule. BVA may be associated with structural damage to the ascending aorta, which exposes BVA patients to a risk of developing ascending aortic aneurysm and acute aortic accidents. Recent data from the literature have revealed that the natural history of BVA is marked by a possible development towards significant valvulopathy and / or an ascending aortic aneurysm often requiring surgical treatment. However, the natural history of bicuspid disease remains poorly understood and the prognostic factors for progression to severe valvulopathy and / or aneurysmal dilatation of the ascending aorta remain to be determined.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All patients examined in the echocardiography laboratory whose objective examination was a bicuspid valve of the aortic valve
* Bicuspidia may be formerly known

Exclusion Criteria:

* Refusal to participate
* Patients who had already undergone bicuspid surgery or ascending aorta before being examined at the echocardiography laboratory

Conditions2

Aortic Valve, BicuspidHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.